Market Cap (In USD)
1.46 Million
Revenue (In USD)
-
Net Income (In USD)
-29.18 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.13-0.25
- PE
- -
- EPS
- -
- Beta Value
- 0.821
- ISIN
- IL0010954050
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Yoram Azulai
- Employee Count
- -
- Website
- https://www.hbl.co.il
- Ipo Date
- 2010-10-27
- Details
- Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.
More Stocks
-
1848
-
HTZ
-
KIOCLKIOCL Limited
KIOCL
-
BILL
-
BAUT
-
AEHL
-
MDBH
-
GATXGATX Corporation
GATX